We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Target Healthcare Reit Plc | LSE:THRL | London | Ordinary Share | GB00BJGTLF51 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.30 | 1.72% | 77.00 | 76.90 | 77.20 | 79.00 | 75.80 | 79.00 | 1,334,742 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 67.75M | -6.57M | -0.0106 | -72.55 | 476.96M |
TIDMTHRL
RNS Number : 7576I
Target Healthcare REIT Limited
02 September 2016
Target Healthcare REIT Limited
Extension of Debt Facilities
The Board of Target Healthcare REIT Limited (the "Company" and together with its subsidiaries, the "Group") is pleased to announce that it has agreed with The Royal Bank of Scotland plc ("RBS") to amend and restate the terms of its existing GBP30 million committed term loan and GBP20 million revolving credit facility (together the "Facilities").
The term of the Facilities has been extended from June 2019 to August 2021. In addition, the amendment also provides an option of two further one year extensions thereafter, subject to the consent of RBS.
Interest is payable under the Facilities at a rate equal to three month LIBOR plus a lending margin of 1.50 per cent. per annum. This represents a reduction of 50 basis points on the previous margin of 2 per cent. per annum. There are no other material amendments to the Facilities.
As previously announced, the Group already benefits from an interest rate swap agreement with RBS to fix its interest payments on a notional GBP21 million of loans to June 2019 at a rate of 0.85 per cent. plus the lending margin. On the basis the Facilities are fully drawn, this effectively fixes the interest payments on 42 per cent. of the Company's available debt at a newly lowered fixed rate of 2.35 per cent.
As at 31 August 2016 the Group's borrowings were GBP21 million, giving a loan-to-value ratio of 9.4 per cent. (calculated as total gross debt as a proportion of gross property value. As the Group expects to invest the majority of its current cash balance in new care homes, cash has been excluded from the calculation.).
The new Facilities will allow the Group to manage its capital structure in line with its investment policy. Namely, that borrowings over the medium term will represent approximately 20 per cent. of the Group's gross assets at the time of draw down, whilst the revolving credit facility will also provide shorter-term flexible capital to fund the growth of the Group's property portfolio.
In the event that the full amount is drawn down under the Facilities the Group's gearing is expected to be approximately 17 per cent. of the Group's gross assets.
Enquiries:
Kenneth MacKenzie
Target Advisers
01786 845 912
Mark Young, Neil Winward, Tom Yeadon, Roger Clarke
Stifel Nicolaus Europe Limited
020 7710 7600
Martin Cassels
R&H Fund Services Limited
0131 550 3760
Fiona Harris/Sam Emery
Quill PR
020 7466 5058 / 020 7466 5056
Important information
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQFLFBQKFXBBE
(END) Dow Jones Newswires
September 02, 2016 02:00 ET (06:00 GMT)
1 Year Target Healthcare Reit Chart |
1 Month Target Healthcare Reit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions